Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Oaz1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OAZ1 mRNA | CTD | PMID:36331819 | Oaz1 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of OAZ1 mRNA | CTD | PMID:22206623 | Oaz1 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of OAZ1 mRNA | CTD | PMID:22206623 | Oaz1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OAZ1 mRNA | CTD | PMID:17942748 | Oaz1 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of OAZ1 mRNA | CTD | PMID:17942748 | Oaz1 | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of OAZ1 mRNA | CTD | PMID:32145629 | Oaz1 | Rat | 17beta-estradiol | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Estradiol results in increased expression of OAZ1 mRNA | CTD | PMID:39298647 | Oaz1 | Rat | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | affects splicing | ISO | OAZ1 (Homo sapiens) | 6480464 | Metribolone affects the splicing of OAZ1 mRNA | CTD | PMID:17010196 | Oaz1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OAZ1 mRNA | CTD | PMID:17942748 | Oaz1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OAZ1 mRNA | CTD | PMID:32109520|PMID:34747641 | Oaz1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OAZ1 mRNA | CTD | PMID:19465110|PMID:21354282 | Oaz1 | Rat | 2-palmitoylglycerol | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of OAZ1 mRNA | CTD | PMID:37199045 | Oaz1 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of OAZ1 mRNA | CTD | PMID:20188158 | Oaz1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of OAZ1 mRNA | CTD | PMID:30951980 | Oaz1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Oaz1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of OAZ1 mRNA | CTD | PMID:39298647 | Oaz1 | Rat | acrylamide | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of OAZ1 mRNA | CTD | PMID:32763439 | Oaz1 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of OAZ1 mRNA; [bisphenol F co-treated more ... | CTD | PMID:30951980 | Oaz1 | Rat | all-trans-retinoic acid | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of OAZ1 mRNA | CTD | PMID:33167477 | Oaz1 | Rat | antirheumatic drug | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of OAZ1 mRNA | CTD | PMID:24449571 | Oaz1 | Rat | aristolochic acid A | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of OAZ1 mRNA | CTD | PMID:33212167 | Oaz1 | Rat | arsenite(3-) | multiple interactions | ISO | OAZ1 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to OAZ1 mRNA] | CTD | PMID:32406909 | Oaz1 | Rat | benzo[a]pyrene | decreases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of OAZ1 mRNA | CTD | PMID:20127859|PMID:27195522 | Oaz1 | Rat | benzo[a]pyrene | increases methylation | ISO | OAZ1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of OAZ1 3' UTR | CTD | PMID:27901495 | Oaz1 | Rat | benzo[a]pyrene | affects methylation | ISO | OAZ1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of OAZ1 promoter | CTD | PMID:27901495 | Oaz1 | Rat | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of OAZ1 mRNA | CTD | PMID:16648578 | Oaz1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of OAZ1 mRNA | CTD | PMID:33754040 | Oaz1 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:26496021|PMID:36041667 | Oaz1 | Rat | bisphenol A | decreases expression | ISO | Oaz1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of OAZ1 mRNA | CTD | PMID:35598803 | Oaz1 | Rat | bisphenol A | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of OAZ1 mRNA | CTD | PMID:33221593 | Oaz1 | Rat | bisphenol A | affects expression | ISO | OAZ1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of OAZ1 mRNA | CTD | PMID:30903817 | Oaz1 | Rat | bisphenol A | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of OAZ1 mRNA | CTD | PMID:30951980 | Oaz1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of OAZ1 mRNA | CTD | PMID:25181051|PMID:32145629 | Oaz1 | Rat | bisphenol F | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of OAZ1 mRNA | CTD | PMID:30951980 | Oaz1 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Oaz1 | Rat | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of OAZ1 promoter | CTD | PMID:22457795 | Oaz1 | Rat | carbon nanotube | decreases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of OAZ1 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25620056 | Oaz1 | Rat | chloropicrin | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of OAZ1 mRNA | CTD | PMID:26352163 | Oaz1 | Rat | chlorpyrifos | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of OAZ1 mRNA | CTD | PMID:37019170 | Oaz1 | Rat | choline | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Oaz1 | Rat | cobalt dichloride | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of OAZ1 mRNA | CTD | PMID:17553155 | Oaz1 | Rat | deguelin | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | deguelin results in increased expression of OAZ1 mRNA | CTD | PMID:33512557 | Oaz1 | Rat | dimethylarsinic acid | decreases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Cacodylic Acid results in decreased expression of OAZ1 mRNA | CTD | PMID:17441966 | Oaz1 | Rat | doxorubicin | affects response to substance | ISO | OAZ1 (Homo sapiens) | 6480464 | OAZ1 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | Oaz1 | Rat | elemental selenium | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Selenium results in increased expression of OAZ1 mRNA | CTD | PMID:19244175 | Oaz1 | Rat | fenpyroximate | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | fenpyroximate results in increased expression of OAZ1 mRNA | CTD | PMID:33512557 | Oaz1 | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of OAZ1 mRNA | CTD | PMID:23962444 | Oaz1 | Rat | folic acid | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of OAZ1 mRNA; [Methionine deficiency co-treated more ... | CTD | PMID:20938992|PMID:22206623 | Oaz1 | Rat | folic acid | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of OAZ1 mRNA | CTD | PMID:21867686 | Oaz1 | Rat | glyphosate | decreases methylation | EXP | | 6480464 | Glyphosate results in decreased methylation of OAZ1 gene | CTD | PMID:31011160 | Oaz1 | Rat | hydralazine | multiple interactions | ISO | OAZ1 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of OAZ1 mRNA | CTD | PMID:17183730 | Oaz1 | Rat | L-methionine | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Oaz1 | Rat | lactacystin | increases expression | EXP | | 633446 | Lactacystin increases expression of Oaz1 protein in endothelial cells | RGD | | Oaz1 | Rat | leptomycin B | increases localization | EXP | | 401851056 | Leptomycin B increases localization of Oaz1 protein in the nucleus | RGD | | Oaz1 | Rat | menadione | affects expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of OAZ1 mRNA | CTD | PMID:20044591 | Oaz1 | Rat | paracetamol | affects expression | ISO | Oaz1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of OAZ1 mRNA | CTD | PMID:17562736 | Oaz1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Oaz1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OAZ1 mRNA | CTD | PMID:36331819 | Oaz1 | Rat | pinosylvin | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | pinosylvin results in decreased expression of OAZ1 mRNA | CTD | PMID:23333577 | Oaz1 | Rat | pyrimidifen | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of OAZ1 mRNA | CTD | PMID:33512557 | Oaz1 | Rat | rotenone | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Rotenone results in increased expression of OAZ1 mRNA | CTD | PMID:33512557 | Oaz1 | Rat | selenium atom | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Selenium results in increased expression of OAZ1 mRNA | CTD | PMID:19244175 | Oaz1 | Rat | sodium arsenite | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of OAZ1 mRNA | CTD | PMID:38568856 | Oaz1 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of OAZ1 mRNA | CTD | PMID:19281266 | Oaz1 | Rat | sunitinib | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of OAZ1 mRNA | CTD | PMID:31533062 | Oaz1 | Rat | tebufenpyrad | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of OAZ1 mRNA | CTD | PMID:33512557 | Oaz1 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of OAZ1 mRNA | CTD | PMID:15336504 | Oaz1 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of OAZ1 mRNA | CTD | PMID:26496021 | Oaz1 | Rat | titanium dioxide | decreases methylation | ISO | Oaz1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of OAZ1 promoter | CTD | PMID:35295148 | Oaz1 | Rat | trans-pinosylvin | decreases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | pinosylvin results in decreased expression of OAZ1 mRNA | CTD | PMID:23333577 | Oaz1 | Rat | trichloroethene | decreases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of OAZ1 mRNA | CTD | PMID:28973375 | Oaz1 | Rat | triphenyl phosphate | affects expression | ISO | OAZ1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of OAZ1 mRNA | CTD | PMID:37042841 | Oaz1 | Rat | tungsten | increases expression | ISO | Oaz1 (Mus musculus) | 6480464 | Tungsten results in increased expression of OAZ1 mRNA | CTD | PMID:30912803 | Oaz1 | Rat | valproic acid | multiple interactions | ISO | OAZ1 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of OAZ1 mRNA | CTD | PMID:17183730 | Oaz1 | Rat | valproic acid | increases expression | ISO | OAZ1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of OAZ1 mRNA | CTD | PMID:23179753 | Oaz1 | Rat | vincaleukoblastine | affects response to substance | ISO | OAZ1 (Homo sapiens) | 6480464 | OAZ1 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















